Daiichi can access previous asset declarations by Singh Brothers on affidavit of confidentiality
Ranbaxy contributes a little lower than Rs 3k cr to the India sales of the merged entity
The older drugs belong to erstwhile Ranbaxy Labs and have not been marketed in the US since 2008
Malvinder Singh and Shivinder Singh were accused of concealing information regarding wrongdoing at Ranbaxy when they sold a majority stake in it to the Japanese firm in 2008
The two had sold their entire stake of about 35% in Ranbaxy for $2.4 bn in 2008 to Daiichi Sankyo